Results 11 to 20 of about 3,368,571 (283)

The rapid rebound of invasive meningococcal disease in France at the end of 2022

Journal of Infection and Public Health, 2023
Background: Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic. A rebound in IMD cases was feared upon easing these measures.
Samy Taha, Eva Hong, Mélanie Denizon, Michael Falguières, Aude Terrade, Ala-Eddine Deghmane, Muhamed-Kheir Taha   +6 more
doaj   +1 more source

Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules

BMC Infectious Diseases, 2021
Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 
Eva Hong, Aude Terrade, Mélanie Denizon, Myriam Aouiti-Trabelsi, Michaël Falguières, Muhamed-Kheir Taha, Ala-Eddine Deghmane   +6 more
doaj   +1 more source

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France

npj Vaccines, 2022
Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha, Muhamed-Kheir Taha, Ala-Eddine Deghmane   +2 more
doaj   +1 more source

Product review on the IMD serogroup B vaccine Bexsero®

Human Vaccines & Immunotherapeutics, 2022
Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj   +1 more source

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

BMC Research Notes, 2020
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj   +1 more source

Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review

Infectious Diseases and Therapy, 2023
Introduction Invasive meningococcal disease (IMD) due to serogroup W meningococci (MenW) is consistently reported with atypical clinical manifestations, including gastrointestinal symptoms, bacteremic pneumonia, and septic arthritis.
Isabelle Bertrand-Gerentes, Laurent Fanchon, Florence Coste, Richard E. Glover, Tamazoust Guiddir, Muhamed-Kheir Taha   +5 more
doaj   +1 more source

Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach

Chemical Reviews, 2021
The glycocalyx, a thick layer of carbohydrates, surrounds the cell wall of most bacterial and parasitic pathogens. Recognition of these unique glycans by the human immune system results in destruction of the invaders.
P. Seeberger
semanticscholar   +1 more source

Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease

Journal of Infectious Diseases, 2021
Haemophilusinfluenzae serotype b (Hib) is an important cause of serious, invasive infections, particularly in young children. Since 1985, a series of vaccines composed of the type b capsular polysaccharide polyribosylribitol phosphate (PRP), followed by ...
J. Gilsdorf
semanticscholar   +1 more source

Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon

International Journal of Infectious Diseases, 2020
Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang, Ariane Nzouankeu, Eva Hong, Aude Terrade, Mélanie Denizon, Ala-Eddine Deghmane, Suzie Moyo Tetang Ndiang, Eric-Walter Pefura-Yone, Véronique Penlap Beng, Richard Njouom, Marie-Christine Fonkoua, Muhamed-Kheir Taha   +11 more
doaj   +1 more source

A Case of <i>Haemophilus influenzae</i> Colonisation in Bronchiectasis Following COVID-19: Post-COVID-19 Bronchiectasis as a Structural Hotbed for Chronic Airway Infections. [PDF]

Respirol Case Rep
Oi I, Okada Y, Fujimoto N, Yoshimura S, Toyama S, Ito T, Imakita T, Kanai O, Fujita K, Tanizawa K.   +9 more
europepmc   +3 more sources